View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| HHS/FDA | RIN: 0910-AC30 | Publication ID: Spring 2011 |
| Title: Medical Devices; Anesthesiology Devices; Reclassification of Pressure Regulators for Use With Medical Oxygen; and Separate Classification of Oxygen Conserving Devices | |
| Abstract: The Food and Drug Administration (FDA) issued a proposed rule to reclassify pressure regulators for use with medical oxygen from class I to class II, establish a separate classification for oxygen conserving devices, and establish a special control for these devices to address problems of fire and explosion associated with use of these devices. The special control discussed in the proposed rule is a guidance document that includes standardized testing, performance, and labeling guidance for industry. Under the proposed rule, oxygen pressure regulators that meet the standard identified in a special controls guidance document would be exempt from the premarket notification requirements of the Federal Food, Drug, and Cosmetic Act. FDA anticipates that the requirements of a final rule would be phased-in to minimize the cost of complying with the special control. | |
| Agency: Department of Health and Human Services(HHS) | Priority: Substantive, Nonsignificant |
| RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Completed Actions |
| Major: No | Unfunded Mandates: No |
| CFR Citation: 21 CFR 868.2700 21 CFR 868.2750 21 CFR 868.5905 21 CFR 868.5910 | |
| Legal Authority: 21 USC 351 21 USC 360 21 USC 360c 21 USC 360e 21 USC 360j 21 USC 371 | |
|
Legal Deadline:
None |
||||||||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: Undetermined | Government Levels Affected: Undetermined |
| Federalism: Undetermined | |
| Included in the Regulatory Plan: No | |
| RIN Data Printed in the FR: No | |
|
Agency Contact: Madhusoodana Nambiar Regulatory Counsel Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health, WO 66, Room 5518, 10903 New Hampshire Avenue, Silver Spring, MD 20993 Phone:301 796-5837 Fax:301 847-8145 Email: madhusoodana.nambiar@fda.hhs.gov |
|
An official website of the United States government



